NASDAQ:VCEL
Vericel Corporation
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
vcel.comipo date
Feb 04, 1997
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and sin...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus